Study: NCT03892616

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (B)
Description: Tablet formulation 2 (TF2a), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (B)
Description: Tablet formulation 2 (TF2a), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (B)
Description: Tablet formulation 2 (TF2a), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (B)
Description: Tablet formulation 2 (TF2a), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (B)
Description: Tablet formulation 2 (TF2a), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (B)
Description: Tablet formulation 2 (TF2a), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (B)
Description: Tablet formulation 2 (TF2a), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (C)
Description: Tablet formulation 2 (TF2a), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (C)
Description: Tablet formulation 2 (TF2a), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (C)
Description: Tablet formulation 2 (TF2a), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (C)
Description: Tablet formulation 2 (TF2a), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (C)
Description: Tablet formulation 2 (TF2a), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (C)
Description: Tablet formulation 2 (TF2a), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (C)
Description: Tablet formulation 2 (TF2a), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (D)
Description: Tablet formulation 2 (TF2b), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (D)
Description: Tablet formulation 2 (TF2b), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (D)
Description: Tablet formulation 2 (TF2b), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (D)
Description: Tablet formulation 2 (TF2b), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (D)
Description: Tablet formulation 2 (TF2b), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (D)
Description: Tablet formulation 2 (TF2b), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (D)
Description: Tablet formulation 2 (TF2b), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (E)
Description: Tablet formulation 2 (TF2b), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (E)
Description: Tablet formulation 2 (TF2b), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (E)
Description: Tablet formulation 2 (TF2b), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (E)
Description: Tablet formulation 2 (TF2b), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (E)
Description: Tablet formulation 2 (TF2b), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (E)
Description: Tablet formulation 2 (TF2b), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (E)
Description: Tablet formulation 2 (TF2b), fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894 (A)
Description: Tablet formulation 1 (TF1), fed